"These survey results are clear: the American people want policy makers to support cutting-edge research that will enable biotechnology to fulfill its potential to heal, fuel and feed the world," said Mr Jim Greenwood, president and CEO of BIO.

He added: " We are at a critical crossroads. We need policies in place that support investment in biotech innovation and a more streamlined regulatory process that properly protects patient safety and speeds the delivery of breakthrough medicines and cures of sick patients or we risk losing America's leadership in biotech innovation."

Some of the other highlights of the finding are:

• A majority (68 per cent) of industry leaders cited partisan policy gridlock I the US government as a critical concern over the next 5-10 years
• A majority of American voters rate finding cures to serious diseases such as cancer, Parkinson's and HIV/AIDS second in importance only to improving the economy ahead of combating terrorism.
• Over 62 per cent of industry leaders said lack of available capital is going to be a difficult challenge over the next 5-10 years. Five years ago, only 33 per cent of the respondents had similar apprehensions.